We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers (LIBRE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02087592
Recruitment Status : Active, not recruiting
First Posted : March 14, 2014
Last Update Posted : October 26, 2022
Sponsor:
Information provided by (Responsible Party):
Technical University of Munich

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian cancer during their lifetime. There is evidence from the literature that for sporadic breast cancer disease risk and the course of disease can be significantly influenced by physical activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized multicenter feasibility trial is that a structured life-style intervention program with exercise training and mediterranean diet is feasible and improves the nutritional and fitness status as well as the weight, the quality of life and stress reacting capacity.

Condition or disease Intervention/treatment Phase
Hereditary Breast and Ovarian Cancer Behavioral: Structured exercise training plus mediterranean diet Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 69 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2 Mutations
Actual Study Start Date : February 2014
Actual Primary Completion Date : November 2014
Estimated Study Completion Date : December 2023

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: Control
Usual standard of care
Experimental: Intervention
Usual standard of care plus structured physical exercise training plus mediterranean-style diet
 Behavioral: Structured exercise training plus mediterranean diet


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of patients successfully completing the intervention program [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. Stress coping capacity (TICS) [ Time Frame: 3 months ]
  2. Grade of optimism (LOT) [ Time Frame: 3 months ]
  3. Body mass index as a marker of caloric balance [ Time Frame: 3 months ]
  4. Total fat intake [ Time Frame: 3 months ]
  5. maximum exercise capacity (VO2max) as a marker of physical fitness [ Time Frame: 3 months ]
  6. Quality of life (SF-36) [ Time Frame: 3 months ]
  7. Physical activity (IPAQ questionnaire) [ Time Frame: 3 months ]

Other Outcome Measures:
  1. Anthropometric parameters (waist and hip circumference, skinfold measurements) [ Time Frame: 3 months ]
  2. Body composition (body impedance analysis) [ Time Frame: 3 months ]
  3. Eating behaviour [ Time Frame: 3 months ]
  4. Laboratory parameters [ Time Frame: 3 months ]
  5. Aerobic exercise capacity during ergometry [ Time Frame: 3 months ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 69 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • women with proven pathogenic BRCA1/2 mutation

Exclusion Criteria:

  • metastatic tumor disease
  • life expectancy <3 years
  • clinically limiting cardiovascular or respiratory disease
  • significant orthopedic disability which prevents from participating in the exercise training
  • severe concomitant disease which prevents from participating in the group interventions
  • Karnofsky index <60
  • VO2max >150%
  • Maximal exercise capacity < 50 W
  • food allergies which prevent from mediterranean diet
  • vegan diet
  • body mass index <15 kg/m2
  • pregnancy
  • insufficient knowledge of German language
  • insufficient compliance
  • active participation in other interventional trials
  • no informed consent
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02087592


Locations
Layout table for location information
Germany
University of Cologne
Cologne, Germany
University of Schleswig-Holstein Campus Kiel
Kiel, Germany
Technische Universitaet Muenchen
Munich, Germany
Sponsors and Collaborators
Technical University of Munich
Investigators
Layout table for investigator information
Principal Investigator: Marion Kiechle, Prof. Dr. Technical University of Munich
Study Director: Martin Halle, Prof. Dr. Technical University of Munich
Study Director: Stephan C Bischoff, Prof. Dr. Universitaet Hohenheim, Stuttgart
Study Director: Wolf-Dieter Gerber, Prof. Dr. Universitaetsklinikum Schleswig-Holstein, Campus Kiel
Study Director: Markus Loeffler, Prof. Dr. University of Leipzig
Study Director: Christoph Engel, Dr. University of Leipzig
Study Director: Rita K Schmutzler, Prof. Dr. University of Cologne
Study Director: Alfons Meindl, Prof. Dr. Technical University of Munich
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Technical University of Munich
ClinicalTrials.gov Identifier: NCT02087592    
Other Study ID Numbers: LIBRE-F-110013
First Posted: March 14, 2014    Key Record Dates
Last Update Posted: October 26, 2022
Last Verified: October 2022
Keywords provided by Technical University of Munich:
hereditary breast and ovarian cancer (HBOC)
BRCA1/2 mutation carriers
Mediterranean diet
Structured exercise training
prevention
Additional relevant MeSH terms:
Layout table for MeSH terms
Ovarian Neoplasms
Hereditary Breast and Ovarian Cancer Syndrome
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Neoplasms, Female
 Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders
Breast Neoplasms
Neoplastic Syndromes, Hereditary
Genetic Diseases, Inborn
Breast Diseases
Skin Diseases